Stay updated on Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page.

Latest updates to the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check34 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check49 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various proteins and antibodies related to renal cell carcinoma. Notably, previous mentions of specific antineoplastic agents and molecular mechanisms have been removed.SummaryDifference2%

- Check77 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page.